Massachusetts has one of the strongest innovation-funding ecosystems in the country -- anchored by a 10% state R&D credit, a federal R&D offset worth up to $500K/year, NIH and NSF SBIR funding that flows heavily into Greater Boston and Cambridge, and a unique 90% cash refundability feature for MLSC-certified life sciences companies. This guide covers what's real, what's restricted, and how programs stack together.
The biggest MA-specific opportunity most founders miss: the MA R&D credit is 10% incremental (15% for MIT/Harvard/UMass sponsored research agreements), and MLSC-certified life sciences companies can receive 90% of unused credits as cash -- turning a non-refundable credit into real money. Hard gate: the MA credit is C-corps and S-corps only; LLCs get nothing until they convert. Federal Section 41 R&D credit (up to $500K/yr payroll offset) applies to all entity types and stacks on top. NIH SBIR Phase I (up to $323K) is the primary non-dilutive grant path for Kendall Square and Longwood Medical Area biotechs.
Most federal programs are available nationally, but Massachusetts businesses -- especially those in Greater Boston, Cambridge, and the Route 128 corridor -- capture a disproportionate share of certain federal programs. NIH SBIR, NSF SBIR, and the Section 41 R&D credit are the three worth prioritizing first.
Up to $500,000 per year in payroll-tax offset for qualified small businesses (QSBs) -- applies regardless of entity type (LLCs included). Any business with qualifying R&D wages should claim this before any other program. File Form 6765 with your federal tax return.
The federal Section 41 R&D credit gives you 20% of your qualified research expenses (QREs) above your historical base using the regular method, or 14% via the simpler Alternative Simplified Credit (ASC). For most early-stage companies, the ASC is easier: 14% of QREs exceeding 50% of your 3-year average QRE.
The payroll-tax offset feature is what makes this transformative for pre-revenue MA startups: a "qualified small business" (under $5M gross receipts, under 5 years old) can elect to offset up to $500,000 per year in employer Social Security taxes directly. You get the credit even if you have no taxable income.
For a Cambridge biotech with $600K in qualifying wages and no revenue, this translates to roughly $80K--$84K in the first year (14% of QREs above 50% of a 3-year average starting from zero). The offset starts hitting payroll taxes the quarter after you file -- typically Q1 or Q2 of the following year.
Source: IRS Form 6765 instructions; IRS.gov/businesses/research-creditHere is what you need to know about Section 41 specifically for Massachusetts founders:
What counts as a QRE in a lab-heavy biotech? Wages paid to employees conducting qualified research activities (lab bench work, coding, engineering) are the primary component. Contract research is eligible at 65% of the amount paid to a domestic contractor. Supplies consumed in research (reagents, cell culture media, cloud compute for ML training) are eligible. Equipment is not -- it depreciated under other sections.
The Kendall Square pattern: Many early MIT and Harvard spinouts are organized as LLCs or LLPs for VC tax reasons. These entities can still claim the federal Section 41 credit -- it flows through to partners/members on K-1s -- but they cannot claim the Massachusetts R&D credit (which is C-corp and S-corp only). If you expect to raise institutional VC and are currently an LLC, model the C-corp conversion timeline with your accountant. The first year after conversion, you would start building the MA base-period QRE history needed for the incremental credit calculation.
SBIR interaction: Federal SBIR awards are "funded research" under Section 41(d)(4)(H) -- research funded by a government contract where the government retains rights to the results. Wages and expenses funded by an SBIR award do not qualify for the R&D credit (federal or state). This is a common planning gap: NIH SBIR Phase I funds your feasibility study, but all those wages become ineligible QREs for that period. Structure your internal unfunded R&D carefully alongside SBIR-funded work to preserve credit eligibility.
Stacking with MA credit: You claim the federal credit on Form 6765 and the MA credit on Schedule RC (Form 355). They are computed on the same underlying QREs, but the MA credit only counts expenses located in Massachusetts. If your company has labs both in Cambridge and in, say, San Diego, only the Massachusetts-located wages and supplies qualify for the MA credit. The federal credit applies to all US-located research.
Documentation you need before claiming: contemporaneous project-level timesheets or effort allocations by employee, payroll records by employee, supply invoices keyed to project codes, and a qualified research activity description for each project meeting the four-part test (technological uncertainty, process of experimentation, technological in nature, qualified purpose). A tax advisor with R&D credit experience can run a documentation review in about a day; cost is typically $3,000--$10,000 but the credit often returns $50K--$500K annually.
| Method | Rate | Best for |
|---|---|---|
| Regular Incremental | 20% of QREs above base | Companies with consistent long R&D history (1984-1988 base period available) |
| Alternative Simplified Credit (ASC) | 14% of QREs above 50% of 3-yr avg | Startups and young companies without base-period history -- simpler math |
| QSB Payroll Offset | Up to $500K/yr vs. payroll taxes | Pre-revenue companies under 5 yrs old / under $5M gross receipts |
Greater Boston, Cambridge, and the Longwood Medical Area are among the most productive NIH SBIR corridors in the country. The National Institutes of Health funds 27 institutes and centers, each with its own topical priorities: NCI for cancer diagnostics and therapeutics, NIBIB for imaging and devices, NIMH for mental health technology, NIDDK for metabolic diseases, and NHGRI for genomics applications. Kendall Square companies -- those in the Cambridge, Somerville, and East Cambridge biotech cluster -- have consistently captured significant Phase I and Phase II SBIR funding.
Phase I awards are up to $323,090 total costs for a 6-month feasibility study. A successful Phase I positions the company for Phase II (up to $2,153,927) and, through the SBIR to Phase III "commercialization bridge," for non-SBIR federal procurement. The program runs three annual receipt cycles: September 5, January 5, and April 5 -- fixed dates year-over-year.
| Factor | NIH SBIR | NSF SBIR (America's Seed Fund) |
|---|---|---|
| Phase I award | Up to $323,090 | Up to $305,000 |
| Topic focus | Biomedical, health tech, medical devices, digital health | Any deep tech: engineering, materials, AI, agtech, cleantech |
| Application entry | Full application (Specific Aims + Research Plan) | 3,500-char Project Pitch first; full proposal by invitation only |
| Receipt cycles / yr | 3 (Sept 5, Jan 5, Apr 5) | Continuous rolling (Pitch Portal open year-round) |
| Review process | Formal study section peer review, scored 1-9 | Program officer review of pitch; invited proposals reviewed by panels |
NIH SBIR for life sciences; NSF SBIR for deep tech, hardware, or anything that crosses multiple domains. DoD SBIR for defense applications or dual-use tech. Run NIH and NSF concurrently when technically eligible -- they don't conflict.
Most Kendall Square biotechs start with NIH SBIR because the disease-area alignment is clearest. But several MA founders have benefited from running NIH and NSF applications simultaneously -- NIH for the biological mechanism, NSF for the underlying technology platform. NSF's Project Pitch is a low-effort first screen (3,500 characters, reviewed in 30 days) that tells you whether to invest in a full proposal.
DoD SBIR and STTR (through DARPA, DTRA, Army, Navy, Air Force, and other components) is highly relevant for Cambridge and Waltham defense-adjacent companies. DoD SBIR solicitations are topic-driven -- you identify a specific BAA topic number that matches your technology, not a general agency. Check SBIR.gov for open DoD solicitations.
The MA SBIR/STTR advantage: the state does not operate a separate SBIR matching grant program (unlike Illinois, which has DCEO matching), but Massachusetts companies benefit from strong local SBIR infrastructure. MassBIO, the Massachusetts Biotechnology Council, offers grant-writing workshops and peer connections. MIT's Deshpande Center and Harvard Innovation Labs provide application support to affiliated founders.
Here is what you need to know about STTR and tech transfer for Massachusetts founders who started at MIT or Harvard:
STTR vs SBIR: STTR (Small Business Technology Transfer) requires a formal research partnership with a US research institution (MIT, Harvard, UMass, Tufts, Boston University, etc.). Phase I awards are the same dollar amounts as SBIR -- up to $323,090 for NIH STTR Phase I, up to $305,000 for NSF. The research institution must perform at least 30% of the work. In return, you get access to the university's facilities, equipment, and IP. If your company licensed foundational IP from MIT or Harvard TLO, an STTR is often the natural follow-on funding to advance that IP.
IP ownership: STTR requires a written agreement specifying IP ownership and rights before award. MIT and Harvard have standard-form agreements for STTR partnerships. If the university owns the background IP, your STTR agreement needs to address how the company retains commercialization rights to foreground IP developed under the award. MIT TLO and Harvard OTD both have experience structuring these agreements -- engage them early.
The university partnership rate (15% MA credit): Separately from STTR, any C-corp making basic research payments to MIT, Harvard, UMass Amherst, UMass Medical School, Boston University, Northeastern, Tufts, or other Massachusetts research institutions qualifies for the 15% Massachusetts R&D credit rate (vs. 10% for internal QREs). If you have a sponsored research agreement (SRA) with MIT for $500K of basic research, the MA credit on that SRA is $75K (15% of $500K), compared to approximately $50K you would get from equivalent internal QREs. This is one of the most underused MA credit opportunities for biotech and cleantech companies in Greater Boston and Cambridge.
MIT Sandbox Innovation Fund: MIT Sandbox provides $5,000--$25,000 in project grants to MIT student and alumni startup teams, plus connections to MIT mentors and the Deshpande Center. This is not a competitive federal SBIR -- it is a university seed mechanism. It is worth accessing early because MIT Sandbox alumni have preferential access to MIT startup resources and are competitive NIH SBIR applicants once they build preliminary data.
10% of incremental MA-located QREs above your historical base (or 10% via the ASC: QREs above 50% of 3-year average). Alternatively, 15% on basic research payments to Massachusetts universities. 15-year carryforward. MLSC-certified companies can receive 90% of unused credits as a cash refund -- this is the mechanism that makes the non-refundable credit actually pay out for early-stage life sciences companies.
Track 1: Standard Incremental. 10% of current-year Massachusetts QREs minus the base amount (computed using 1984-1988 base QREs or a startup rule). Most straightforward for companies with a few years of MA-located research history. File Schedule RC attached to Form 355 (C-corp) or Form 355S (S-corp).
Track 2: Alternative Simplified Credit (ASC). Available since the 2014 Economic Development Act, phased to 10% by 2021. Calculate 10% of Massachusetts QREs exceeding 50% of your average QREs for the prior 3 tax years. Simpler math, good for startups. The ASC election must be made on the first return you claim it and binds you for 3 consecutive years.
Track 3: University Basic Research Payments. 15% on payments for basic research made to Massachusetts-based universities or research consortia -- MIT, Harvard, Boston University, UMass (Amherst, Boston, Medical School, Lowell, Dartmouth), Northeastern, Tufts, Worcester Polytechnic Institute, and qualifying research consortia. "Basic research" under Section 41(e)(2) means original investigation for the advancement of scientific knowledge without a specific commercial objective. This rate is 50% higher than the standard 10% and substantially underused by Massachusetts biotechs with sponsored research agreements.
Source: M.G.L. c. 63, Section 38M; 830 CMR 63.38M.1; TIR 14-16Here is what you need to know about converting the non-refundable MA R&D credit into a cash payment through MLSC certification:
What MLSC certification is: The Massachusetts Life Sciences Center (MLSC) administers the Life Sciences Tax Incentive Program under M.G.L. c. 23I. Certified companies can receive up to 90% of unused Massachusetts R&D credits as a cash refund, paid by the state. The program is capped statewide -- typically $30M--$40M in refunds are distributed annually among certified companies.
Who qualifies: Life sciences companies (biotech, pharma, medical devices, digital health, diagnostics, CROs, agricultural biotech) operating in Massachusetts with significant Massachusetts-based employment. Companies are certified by MLSC based on their economic impact plan -- planned MA hiring, capital investment in MA facilities, and R&D activity. The application window runs approximately January 12 through March 31 each year.
How the refund works: You still file Schedule RC with your MA Form 355 and generate the credit normally. The MLSC-certified portion of your unused credits (those that couldn't be used because they exceeded your tax liability or the 75%-of-excess limitation) are submitted to the MLSC program separately. MLSC then issues a payment -- 90% of the eligible unused credits -- directly to the company. This is real cash, not a credit. A company with $200,000 in unused MA R&D credits could receive $180,000 in cash refunds through this mechanism.
MassCEC parallel: The Massachusetts Clean Energy Center (MassCEC) operates a separate certification program for climatetech companies. MassCEC-certified companies can also access 90% refundability on unused MA R&D credits. Greentown Labs members (Somerville) and MassCEC portfolio companies frequently access this path. The MassCEC certification process is separate from the MLSC application -- apply to the program that matches your sector.
Coordination between MLSC and SBIR: SBIR-funded research expenses are excluded from both federal and state QREs (funded research exclusion). Plan the MLSC application to document only unfunded research activities in your economic impact narrative. Your company can simultaneously be MLSC-certified and hold an active NIH SBIR award -- you simply exclude the SBIR-funded wage costs from your QRE calculation.
| Feature | MA R&D Credit (Schedule RC) | Federal Section 41 (Form 6765) |
|---|---|---|
| Rate | 10% incremental; 15% university basic research | 20% regular; 14% ASC |
| Entity types | C-corps and S-corps only (LLCs excluded) | All entities (C-corps, S-corps, LLCs, partnerships, sole proprietors) |
| Refundability | Non-refundable (90% cash refund via MLSC/MassCEC for certified companies) | Non-refundable income credit; up to $500K/yr payroll offset for QSBs |
| Geographic scope | MA-located QREs only | All US-located QREs |
| Carryforward | 15 years (75%-rule disallowed portion: indefinite) | 20 years |
| Stackable with each other | Yes -- claim both on the same MA-located spend | |
| Program | MLSC Tax Incentive | MassCEC ClimaTech Program |
|---|---|---|
| For | Life sciences (biotech, pharma, medical devices, diagnostics, CROs) | Clean energy and climatetech (solar, storage, efficiency, climate adaptation) |
| Application window | Jan-March each year | Rolling (contact MassCEC for current cycle) |
| Refund mechanism | 90% of unused MA R&D credits paid as cash | 90% of unused MA R&D credits paid as cash |
| Anchor ecosystem | Kendall Square, Longwood Medical Area, Route 128 biotech corridor | Greentown Labs (Somerville), MassCEC portfolio, coastal/offshore wind |
MassDevelopment absorbed the Massachusetts Growth Capital Corporation (MGCC) in February 2025. The combined entity administers the Small Business Technical Assistance (SBTA) grant program -- $6.7M awarded in FY26 to 73 organizations statewide. Small businesses access services free through these intermediaries.
| Route | Who it serves | How to access |
|---|---|---|
| SBTA Free TA Services | Businesses under 20 employees, under $2.5M revenue | Find an SBTA-funded intermediary at massdevelopment.com or through SBDCs |
| MassDevelopment Direct Financing | Established businesses needing real estate, equipment, or growth capital | Apply directly at massdevelopment.com (loans, bond financing, real estate) |
| FY27 SBTA RFP (for nonprofits) | CDCs, CDFIs, and community nonprofits wanting to deliver TA | Watch massdevelopment.submittable.com -- RFP expected September 2026 |
You are in one of the strongest biotech funding ecosystems in the world, and your local density opens specific advantages.
First move: entity structure audit. The MA R&D credit is worth nothing until you are a C-corp or S-corp. If you are an LLC preparing to raise a Series A, model the C-corp conversion with your counsel before the next tax year starts. Post-conversion, every dollar of Massachusetts-located R&D wages starts building your credit base.
Second move: NIH SBIR Phase I. Use NIH RePorter to find funded Phase I awards in your specific disease area and institute. Identify your target IC (NCI, NIBIB, NIMH, etc.), find the program officer, and attend a grant writing workshop at MassBIO or HMS/HSDM before you write your specific aims. The Greater Boston biotech community has strong informal networks of SBIR reviewers and former study section members who do informal review -- use them.
Third move: MLSC certification. If you are spending $500K+ per year on Massachusetts-located lab activities and plan to grow MA headcount, apply to MLSC during the January-March window. Certification turns your non-refundable MA R&D credit into a cash payment -- 90% of unused credits paid directly to your company.
Stacking opportunity: For a Cambridge biotech with $1M in MA-located qualifying wages: federal credit (ASC, 14% on $500K above half-average) approximately $70K, plus MA credit (10% on incremental, say $100K above base) approximately $10K, plus MLSC cash refund of up to 90% of that MA credit = real cash out of the credit stack. Add SBIR Phase I ($323K) for a total non-dilutive resource of roughly $400K+ in year one.
Manufacturing companies across Worcester County, Hampden County (Springfield), and Essex County (North Shore -- Salem, Peabody, Beverly, Gloucester) have a different funding profile than Greater Boston tech companies. The key programs are the federal Section 41 R&D credit (most MA manufacturers have process improvement activities that qualify), NSF SBIR if you are doing advanced materials or precision manufacturing R&D, and SBA 7(a) loans for equipment and expansion capital.
R&D credit for manufacturers: Qualifying R&D activities in manufacturing include process improvement through systematic experimentation (redesigning a casting process, developing a new polymer formulation, improving yield on a machining operation), prototype and tooling development for new products, and custom-engineered equipment design. Many manufacturers undercount their qualifying activities. An R&D credit study typically identifies $30K--$200K in annual credit for a 50-person manufacturer with active process engineering.
NSF SBIR for advanced manufacturing: If your company is doing novel materials, precision manufacturing, robotics, or industrial AI -- NSF SBIR Phase I ($305K) is accessible. NSF's manufacturing portfolio is strong, and companies from Worcester, Lowell, and the North Shore have competed successfully.
SBA 7(a) for equipment and expansion: Massachusetts has a strong SBA lending network. Rockland Trust, Eastern Bank, and several CDFIs operate in Worcester, Middlesex, Essex, and Hampden Counties. The SBA 7(a) loan (up to $5M, average around $479K) is the workhorse for equipment purchase, leasehold improvements, and working capital for manufacturers. Preferred Lender Program (PLP) lenders can approve without SBA review -- 2--4 week close.
Contact the Massachusetts Manufacturing Extension Partnership (MMEP) -- a NIST MEP affiliate -- for free manufacturing consulting and referrals to the full state and federal incentive portfolio.
Boston's financial district, Seaport, and Back Bay host a cluster of FinTech and SaaS companies that often overlook available non-dilutive funding because the programs feel designed for hardware or biotech.
The federal R&D credit applies to software. The IRS has clarified that internal-use software developed for sale or license to external customers qualifies under the three-part high-threshold test. If your SaaS company has engineers writing new features, debugging complex systems, or building novel ML models, most of those wages qualify. File Form 6765 annually. For a 10-person SaaS company with $1.5M in engineering payroll, the federal QSB payroll offset often returns $100K--$200K against employer Social Security taxes.
Massachusetts R&D credit for SaaS: C-corps and S-corps are eligible. If you are incorporated as an LLC (common for VC-backed companies), convert to C-corp before applying. The MA credit on Massachusetts engineering wages is 10% incremental -- meaningful for companies with $500K+ in MA-located engineering spend.
NSF SBIR for deep-tech features: FinTech companies building novel AI-driven risk models, privacy-preserving computation (homomorphic encryption, zero-knowledge proofs), or fraud detection systems using novel techniques have successfully accessed NSF SBIR funding. The Project Pitch is low-effort -- 3,500 characters -- and tells you in 30 days whether to invest in a full proposal.
MassChallenge (Boston) runs competitive accelerator cohorts with $500K in equity-free awards distributed annually across its portfolio. It is not a grant program (no cash directly), but access to MassChallenge mentorship and corporate partner connections meaningfully improves competitive positioning for SBIR and private capital.
Massachusetts is among the most supportive US states for cleantech founders, with MassCEC, Greentown Labs, DOE American-Made Challenges, and the MassCEC climatetech refundability path all converging.
MassCEC certification first. If your company is developing clean energy technology in Massachusetts -- offshore wind, energy storage, building electrification, climate adaptation, efficiency tech -- apply for MassCEC certification. Certified companies access 90% cash refundability on unused Massachusetts R&D credits (the same mechanism as MLSC for life sciences). The MassCEC also administers incubator support through its Catalyst program and connects climatetech companies to pilot and demonstration opportunities.
Greentown Labs (Somerville) membership: Greentown Labs, the largest climatetech-focused startup incubator in the US, provides member companies with lab space, equipment access, and connections to corporate partners and VCs focused on climatetech. Membership is competitive but not a grant -- the value is the network and the pilot partnership introductions.
DOE SBIR and American-Made Challenges: DOE SBIR Phase I awards up to $200K for early-stage cleantech R&D. The NREL American-Made Challenges program runs prize competitions ($50K--$3M+) with additional national lab vouchers ($25K--$100K) for cleantech innovators -- these are open-entry prize competitions, not competitive grants. DOE's Office of Science also funds cleantech through its SBIR program for fundamental energy science.
Federal Section 48 ITC: If your company is deploying clean energy assets (solar, storage, fuel cells) in Massachusetts, the Section 48 Investment Tax Credit covers 30% of qualifying installation costs. The Inflation Reduction Act domestic content bonuses (10%) and energy community bonuses (10%) stack on top if applicable. Massachusetts's offshore wind mandate and strong grid-decarbonization policy creates a strong project pipeline for cleantech hardware companies.
Massachusetts has robust infrastructure for MWBE and woman-owned businesses, centered on the SBTA network, SBA Women's Business Centers, and state certification programs.
State certification first. The Massachusetts Office of Business Development (MOBD) and the State Office for Supplier Diversity certify WBE (Woman Business Enterprise) and MWBE (Minority/Women Business Enterprise) businesses. Certification opens opportunities with state procurement and with SBTA-funded intermediaries that prioritize underserved communities. MWBE certification is also accepted by many corporate supplier diversity programs in Greater Boston (Raytheon, Liberty Mutual, Partners HealthCare/Mass General Brigham, Fidelity).
SBTA-funded coaching: MassDevelopment's SBTA program awards $6.7M annually to 70+ intermediaries statewide with explicit priority for organizations serving women and minority entrepreneurs. In Boston, key intermediaries include the Urban League of Eastern Massachusetts, the East Boston Community Development Corporation, and CDFIs serving South Boston, Roxbury, Mattapan, Dorchester, and Lawrence. Access services free -- they help you prepare for SBA microloans and CDFI financing.
SBA Women's Business Centers: Massachusetts has WBC locations serving Greater Boston, Worcester, Springfield, and the South Coast. Free counseling, workshops on QuickBooks and business planning, and warm referrals to SBA Microloan intermediaries (up to $50K).
R&D credits have no gender requirement. All federal and state R&D tax credits are neutral on ownership demographics. A woman-owned C-corp with qualifying R&D wages accesses the exact same Section 41 and MA Schedule RC credits as any other company. The SBTA network and WBCs specifically help women founders document their R&D activities and connect with CPAs experienced in claiming these credits.
| Factor | SBA 7(a) Loan | SBA Microloan |
|---|---|---|
| Maximum amount | $5,000,000 | $50,000 (average ~$13,000) |
| Delivered through | SBA-approved banks and credit unions | Nonprofit CDFI intermediaries |
| Typical borrower | Established business, 2+ yrs operating, some credit history | Startup, thin credit, microbusiness, immigrant entrepreneur |
| Uses | Real estate, equipment, working capital, acquisition, refinancing | Inventory, supplies, working capital, small equipment |
| Close time | 60-90 days (2-4 weeks for PLP lenders) | 2-8 weeks through intermediary |
Massachusetts has 14 counties with distinct economic profiles. The funding programs available do not change by county, but local intermediaries, SBDC offices, SBA lenders, and MLSC-connected advisors vary significantly by region. Here is the local ecosystem by area:
Suffolk County (Boston, Revere, Winthrop, Chelsea) and southern Middlesex County (Cambridge, Somerville, Malden, Medford, Woburn, Waltham, Newton) form the core of the Massachusetts innovation economy. Kendall Square in Cambridge is the global anchor of the biotech corridor, hosting Pfizer, Sanofi, AstraZeneca, Biogen, and hundreds of startups in proximity to MIT. The Longwood Medical Area in Boston's Fenway-Kenmore neighborhood -- home to Harvard Medical School, Brigham and Women's, Mass General, Beth Israel Deaconess, and Boston Children's -- is the second major NIH SBIR engine. The Innovation District in South Boston (Seaport) hosts a concentration of SaaS, FinTech, and climatetech companies.
Key local resources: Cambridge SBDC (MIT campus), Boston SBDC (at various locations), MassBIO for life sciences navigation, MassChallenge (South Boston), Greentown Labs (Somerville, climatetech). SBA lenders: Eastern Bank, Rockland Trust, Citizens Bank, Silicon Valley Bank (now First Citizens, active in biotech), and Mass Development's direct financing programs.
Framingham, Natick, Waltham, Lexington, Needham, Wellesley, and Newton form the MetroWest corridor along Route 128 -- the historic "Technology Highway" that predates Silicon Valley as a tech cluster. Waltham hosts a strong pharma and medical device cluster (Organogenesis, Lantheus, and dozens of diagnostics companies). Framingham has a significant manufacturing base including GCP Applied Technologies. The MetroWest SBDC serves businesses in Middlesex and Norfolk Counties with free consulting. Needham Bank is a strong SBA lender for MetroWest businesses.
Salem, Beverly, Peabody, Lynn, Haverhill, Gloucester, and Lawrence anchor Essex County. Haverhill and Lawrence have significant immigrant entrepreneur populations -- Lawrence hosts multiple SBTA-funded CDFIs with Spanish-language services. The North Shore SBDC (at Salem State University) serves Essex County businesses. Lynn and Salem are in the Greater Boston metropolitan area with good access to MLSC-affiliated advisors. Gloucester has a strong marine technology cluster relevant to NOAA and DOE ocean-energy SBIR programs.
Quincy, Brockton, Weymouth, and Plymouth anchor the South Shore. Quincy is home to a growing professional services and FinTech cluster. Brockton has one of the highest concentrations of immigrant and minority-owned businesses in Massachusetts -- Greater Brockton SBDC and local CDFIs serve this market. South Shore Chamber of Commerce is a referral point for SBA lenders in Plymouth County.
Worcester is the second-largest city in Massachusetts and anchor for Central MA. Worcester Polytechnic Institute (WPI) is an STTR-eligible research partner for engineering and biotech startups. Clark University (Worcester) hosts an SBDC. Biotech and medical device companies in Worcester benefit from proximity to UMass Medical School (a significant STTR partner). The Greater Worcester Community Development Corporation serves minority and immigrant entrepreneurs in Worcester. Framingham State and the College of the Holy Cross are additional potential STTR partners.
Springfield, Holyoke, Chicopee, Northampton, and Amherst form the Pioneer Valley. UMass Amherst is the flagship research university and a major STTR partner for agricultural biotech, materials science, and engineering. Springfield has a manufacturing and distribution base with historically underserved small business communities -- Valley Community Development and other CDFIs operate SBTA-funded programs. The Western MA SBDC (at UMass Amherst) covers Hampshire, Hampden, and Franklin Counties. The Pioneer Valley has lower average wages and cost structure than Greater Boston -- R&D credit QREs are smaller but the credit still applies dollar-for-dollar.
Fall River, New Bedford, and Taunton anchor Bristol County. New Bedford has a significant commercial fishing industry and maritime manufacturing base relevant to NOAA and MARAD SBIR programs. Fall River and Taunton have active textile and manufacturing businesses. The South Coast SBDC serves Bristol County. Cape Cod (Barnstable County) is developing a marine and offshore wind cluster relevant to DOE and NOAA funding -- the Martha's Vineyard and Nantucket offshore wind projects generate supply-chain opportunities. The Cape Cod SBDC (at Cape Cod Community College) serves Barnstable and Dukes Counties.
Pittsfield and North Adams anchor Western Massachusetts's Berkshire County. The Berkshire region has a small manufacturing base and significant arts/tourism economy. The Berkshire SBDC (at Berkshire Community College) serves local businesses. Pittsfield hosts General Electric Power's operations and a community of advanced manufacturing suppliers. Berkshire companies applying for federal SBIR face longer commutes to Boston-based SBIR consultants but can work with UMass Amherst and WPI remotely for STTR partnerships.
| SBIR Agency | Phase I Cap | Best fit for MA companies |
|---|---|---|
| NIH (via PHS) | $323,090 | Biotech, pharma, diagnostics, digital health, medical devices -- Kendall Square, Longwood Medical Area |
| NSF | $305,000 | Deep tech, AI/ML, advanced materials, robotics, agtech, climate tech -- Route 128 corridor, WPI area |
| DOE | $200,000 | Clean energy, energy storage, offshore wind tech, grid modernization -- MassCEC portfolio companies |
| DoD | $250,000 (varies by component) | Defense-relevant AI, cybersecurity, communications, sensors -- Hanscom AFB area, Waltham defense cluster |
| Entity Type | Federal Section 41 | MA Schedule RC | MLSC Refundability |
|---|---|---|---|
| C-Corporation | Yes (income tax or payroll offset) | Yes (against corporate excise) | Yes (if MLSC/MassCEC certified) |
| S-Corporation | Yes (income tax or payroll offset) | Yes (against own corporate excise -- does NOT flow to shareholders) | Eligible (MLSC certification required) |
| LLC (single-member) | Yes (flows to member's return) | No -- excluded | No |
| LLC / Partnership (multi-member) | Yes (flows to partners via K-1) | No -- excluded | No |
| Sole Proprietor | Yes (Schedule C / Form 6765) | No -- excluded | No |
| Institution | Strengths | TLO / Research Office |
|---|---|---|
| MIT (Cambridge) | Engineering, biotech, AI, materials, energy, semiconductors | MIT Technology Licensing Office (TLO) |
| Harvard (Cambridge / Longwood) | Biomedical research, chemistry, computer science, public health | Harvard Office of Technology Development (OTD) |
| UMass Amherst (Hampshire County) | Agricultural biotech, polymer science, AI, advanced manufacturing | UMass Technology Transfer Office |
| UMass Medical School (Worcester) | Gene therapy, RNA biology, neuroscience, oncology | UMass Medical School Technology Transfer |
| WPI (Worcester) | Robotics, mechanical engineering, biomedical engineering | WPI Technology Transfer Office |
| Boston University (Boston) | Photonics, AI, bioinformatics, public health, materials | BU Office of Technology Development |
| Program | Amount | Type | Deadline |
|---|---|---|---|
| Federal R&D Credit (Section 41) | Up to $500K/yr payroll offset | Tax credit | Annual tax filing |
| MA R&D Credit (Schedule RC) | 10% incremental; 15% university | Tax credit | Annual MA tax filing |
| MLSC Tax Incentive (90% refund) | 90% of unused MA R&D credits | Credit refund | Jan-March annually |
| NIH SBIR Phase I | Up to $323,090 | Grant | Sept 5, Jan 5, Apr 5 |
| NSF SBIR Phase I | Up to $305,000 | Grant (Cooperative Agreement) | Rolling (Pitch Portal) |
| SBA 7(a) Loan | Up to $5,000,000 | Loan (guaranteed) | Rolling |
| SBA Microloan | Up to $50,000 | Loan | Rolling (via intermediary) |
| MassDevelopment SBTA | Free TA services (business under $2.5M/20 employees) | Program | Rolling (FY27 RFP: Sept 2026) |
Answer a few questions about your business and get a personalized list of programs you are most likely to qualify for -- including MA R&D credits, SBIR grants, and SBA loans.
Find My Programs FreeMassachusetts small businesses can access more than 20 funding programs in 2026. The strongest non-dilutive options are: the MA R&D Tax Credit (10% incremental, 15% for university basic research, C-corps/S-corps only); the federal Section 41 R&D credit (up to $500,000/yr payroll offset for qualified small businesses, all entity types); NIH SBIR Phase I (up to $323,090 for biotech, health, and medical devices); NSF SBIR Phase I ($305,000 for deep tech); the MLSC Tax Incentive (90% cash refundability for certified life sciences companies); MassDevelopment SBTA (free coaching through 70+ statewide intermediaries); MassCEC climatetech certification; SBA Microloans (up to $50K); and SBA 7(a) loans (up to $5M).
No. The Massachusetts R&D Tax Credit is explicitly limited to business corporations subject to the Massachusetts corporate excise -- C-corps and S-corps. LLCs, partnerships, and joint ventures are excluded by statute (M.G.L. c. 63, Section 38M). LLC-structured Massachusetts biotechs receive zero MA R&D credit until they convert to a C-corp or S-corp. However, LLCs can still claim the federal Section 41 R&D credit, which applies to all entity types and offers up to $500K/year in payroll-tax offsets for qualified small businesses.
The Mass Life Sciences Center (MLSC) Tax Incentive Program allows certified life sciences companies to receive 90% of their unused Massachusetts R&D credits as a cash payment. Without MLSC certification, the MA R&D credit is non-refundable -- you can only use it to offset Massachusetts corporate excise tax. MLSC certification converts the excess (credits above your tax liability) into real cash. The MLSC application window runs approximately January through March each year. MassCEC-certified climatetech companies access the same 90% refundability mechanism through the clean energy certification program.
Massachusetts consistently ranks among the top three states nationally for NIH SBIR award volume and total dollar value, behind California and competing closely with New York and Maryland. The Greater Boston and Cambridge biotech corridor -- anchored by Kendall Square, the Longwood Medical Area, and the Route 128 pharmaceutical cluster -- generates dense NIH SBIR activity. NIH SBIR Phase I awards up to $323,090 for a 6-month feasibility study; Phase II awards go up to $2,153,927. The program runs three annual receipt cycles: September 5, January 5, and April 5.
No. Massachusetts does not operate a standalone state SBIR matching grant program like Illinois (DCEO) or Pennsylvania (Ben Franklin Technology Partners). Massachusetts relies on its high federal SBIR capture rate and strong support infrastructure: MassBIO grant workshops, MIT Sandbox, Harvard Innovation Labs, MassChallenge, and the Massachusetts SBDC network. For early-stage companies that do not win SBIR, the federal Section 41 R&D credit payroll offset (up to $500K/yr) is the alternative non-dilutive mechanism.
For businesses under 20 employees and under $2.5M revenue: find a MassDevelopment SBTA-funded intermediary (CDC, CDFI, or community nonprofit) in your county. Services are free. The Massachusetts SBDC network (lead institution at UMass Boston, sbdc.umb.edu) can refer you to local intermediaries across all 14 counties. For larger financing needs (real estate, equipment, growth capital): apply directly through massdevelopment.com. MassDevelopment absorbed MGCC in February 2025 -- the empoweringsmallbusiness.org domain now redirects to massdevelopment.com.
Greentown Labs (Somerville) is the largest climatetech-focused startup incubator in the US, but it is not itself a grant program. Member companies gain access to lab space, equipment, and the Greentown network of corporate partners and investors. For direct grant funding, Greentown Labs members can pursue: DOE SBIR Phase I (up to $200K), NREL American-Made Challenges prize competitions ($50K-$3M+), MassCEC climatetech certification (90% MA R&D credit refundability), the federal Section 48 ITC (30% for clean energy installations), and the federal Section 41 R&D credit. MassCEC also administers incubator support through the Catalyst program for pre-commercial climatetech companies.
Massachusetts introduced an Alternative Simplified Credit (ASC) under the 2014 Economic Development Act (St. 2014, c. 287), phased in at 5% (2015-2017), 7.5% (2018-2020), and 10% (2021 and later). The MA ASC is calculated on Massachusetts-located QREs exceeding 50% of the average MA QREs for the prior 3 tax years -- the same structure as the federal ASC but applied to Massachusetts-only research spend. The election between the standard incremental method and the ASC must be made on the first return you claim the credit and is binding for 3 consecutive years. The ASC is available alongside the standard 10% incremental method -- you choose which to use.